Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group - Wikidata - wikimedia - TriplyDB

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

http://www.wikidata.org/entity/Q29619842

about

The relationships of markers of cholesterol homeostasis with carotid intima-media thickness Predictors of beta-blocker intolerance and mortality in patients after acute coronary syndrome Fibrates are an essential part of modern anti-dyslipidemic arsenal: spotlight on atherogenic dyslipidemia and residual risk reduction 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease?Ezetimibe for primary hypercholesterolemia Statins for acute coronary syndrome HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis Statins for preventing colorectal adenoma and carcinoma Combined therapy with statins and fibrates for people with dyslipidaemia HMG CoA reductase inhibitors (statins) for kidney transplant recipients Statins for the primary prevention of cardiovascular disease Lipid-lowering agents for nephrotic syndrome Statins for the primary prevention of cardiovascular disease Chronotherapy versus conventional statins therapy for the treatment of hyperlipidaemia Statins for acute coronary syndrome Interventions to improve adherence to lipid lowering medication HMG CoA reductase inhibitors (statins) for kidney transplant recipients HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis Hypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritis Statins for acute coronary syndrome Combined therapy with statins and fibrates for people with dyslipidaemia Ezetimibe for primary hypercholesterolemia Statins and fibrates for preventing melanoma Interventions to improve adherence to lipid lowering medication Lipid-lowering agents for nephrotic syndrome Risk factor thresholds: their existence under scrutiny Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia Effect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study.Diverse effects of inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase on the expression of VCAM-1 and E-selectin in endothelial cells Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapy The associations of cholesterol metabolism and plasma plant sterols with all-cause and cardiovascular mortality Opening a new lipid "apo-thecary": incorporating apolipoproteins as potential risk factors and treatment targets to reduce cardiovascular risk Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis Ezetimibe therapy: mechanism of action and clinical update Plant sterols and cardiovascular disease: a systematic review and meta-analysis Pleiotropic effects of statins Effects of statins on high-density lipoproteins: a potential contribution to cardiovascular benefit Controversial role of plant sterol esters in the management of hypercholesterolaemia Cocoa, chocolate, and cardiovascular disease Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial

P2860

Q21003910-9EE6476D-E218-4366-952D-F4A079D0883B Q21132471-453F3564-CEAB-461E-A069-B2479B41745E Q21246041-E40C622C-1280-4B0D-A46E-D201BF329A50 Q22066036-B5EC736A-91FC-4668-92F1-BCCD9846B8FA Q24187681-7B1D01E8-84B7-4A6A-BDB5-9E86B7687477 Q24193862-73AB1D83-E224-4C5A-8659-299B5CCE1678 Q24194514-F3C13E38-5CAD-44B1-A210-EEAA73E45925 Q24194802-774B4335-B80A-43F2-BA42-736A84056FBF Q24195172-2AC3CB41-3E25-4898-909C-A28408001E2A Q24200984-9229C2AA-7769-4025-9657-CD0ADB091033 Q24201513-D2D8811E-2A5A-445E-9200-FEDB63D0EDED Q24201863-42DC68E5-A488-4085-AD36-3AA79460CA49 Q24234813-8F8ECD98-AF80-4264-B177-1DD3C71ECDC1 Q24235790-78B744FE-3EDF-4D33-A496-22826F160DBD Q24236697-A5DDF5A1-1049-421A-A910-6012C1625260 Q24236817-996D0E31-8A30-4F91-8CC9-826CAAB518DD Q24241098-08D9FEB1-D0C0-4426-8C51-3FC649800233 Q24241472-E7BDE842-2545-4D3C-A33C-DC212783A115 Q24242787-62B97565-43A0-4675-80B5-16E4E0C8AC1E Q24243557-E07C9742-97A9-4E4C-9FC2-B679F6E01102 Q24243737-888DB304-4665-407F-A808-A4927CD571B7 Q24244704-E1C25017-1335-4195-A0DC-01D3D388722C Q24245521-B33A6A29-A996-412A-9583-AA1A34A57BD7 Q24245739-A8103852-DFE6-4FBA-A875-1B86E7965956 Q24246691-1E37C72B-0AD4-4BEE-B03E-9927AD831353 Q24527206-A91384BD-7B72-42EC-ADDB-90FB478DF96B Q24528552-48E81FB1-BE31-4B2F-B792-7DE76097574D Q24531203-1F45380C-B8C9-4D5D-993C-A80831442D86 Q24533532-4231BD95-98A4-4D31-871F-B6218DD4B426 Q24594496-B36E55C5-C6E8-4165-BDFF-41ABE2F02F44 Q24609527-4986C928-6ED4-40DE-86A3-E773ACE77E90 Q24626884-55E639CD-7F7C-4E33-A002-AE43E6C16770 Q24628361-0DECAD8F-7E13-485C-91AD-1D87742CE12C Q24630302-741F300A-5DC7-4270-8D91-6E593761C67C Q24632486-F82CFC95-710A-4482-95A3-22962BB41EEB Q24647863-A60674B1-0FD6-4BC4-8201-4DFC64AA5254 Q24650533-6A91DBC9-B44C-451B-9915-DAE613E1301B Q24653187-DA43DB5E-DCC3-4169-81EB-C231C087E369 Q24654705-93B73D58-62B9-491E-8E7B-36FA336A5904 Q24655535-CB69C6C0-F644-4D50-89F0-C646D754EA23

P2860

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

http://www.wikidata.org/entity/Q29619842

description

1995 nî lūn-bûn

@nan

1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Prevention of coronary heart d ...... oronary Prevention Study Group

@ast

Prevention of coronary heart d ...... oronary Prevention Study Group

@en

type

label

Prevention of coronary heart d ...... oronary Prevention Study Group

@ast

Prevention of coronary heart d ...... oronary Prevention Study Group

@en

prefLabel

Prevention of coronary heart d ...... oronary Prevention Study Group

@ast

Prevention of coronary heart d ...... oronary Prevention Study Group

@en

P1433

Q29619842-9E11A783-9F76-477C-A317-6FB06D65524B

P1476

Q29619842-4F7F6826-251D-4691-9689-56196EA25602

P2093

Q29619842-6D15AEFB-93EA-4AF8-B05C-02D75D1E76F2

Q29619842-7CD24820-9638-4C13-A234-20A099FAC327

Q29619842-9FF29035-272F-4F5E-B0C4-46DC082B0FF8

Q29619842-D91D5199-2E67-42E2-BB0F-33ED149D404F

Q29619842-E2AE26AD-BD4C-4F91-922E-EDFC9C1DCC8A

Q29619842-F7672A3F-FD3D-4F2A-9668-CD474262BC96

Q29619842-F97EB761-5D2C-496A-A15B-359F1A566DDD

Q29619842-FA5A037E-9C7C-4B9B-87CB-E3D7A236EA45

P304

Q29619842-E1971D0A-E2C6-4478-82ED-F44DE4B5AD2E

P31

Q29619842-0F7A85A3-1661-484B-B805-D26547CFD51D

P3181

Q29619842-8CEB9D70-C7CC-45C1-83A8-DA5B75B48346

P356

Q29619842-43EFF686-D41D-4E86-9015-8F790472D3BF

P407

Q29619842-82571DB3-A622-48B3-B13A-0942D0CE6FF2

P433

Q29619842-82FBC72B-01F8-4433-A79F-CC727379775A

P478

Q29619842-E3B0CFF9-81D0-4748-BCCB-74DE92DC6E8E

P577

Q29619842-8FEFFDE6-10EC-4221-A5C5-B712A512C764

P5875

Q29619842-6CA02CBD-D057-4B35-AA35-0C6CCDE7ED9E

P698

Q29619842-6B3A3D0D-3671-4125-9694-9871FDCCA9D5

P921

Q29619842-0C57A49B-8140-404A-9650-7D9EE368ACEC

P3181

P356

NEJM199511163332001

P1433

The New England Journal of Medicine

P1476

Prevention of coronary heart d ...... oronary Prevention Study Group

@en

P2093

Cobbe SM

http://www.w3.org/2001/XMLSchema#string

Ford I

http://www.w3.org/2001/XMLSchema#string

Isles CG

http://www.w3.org/2001/XMLSchema#string

Lorimer AR

http://www.w3.org/2001/XMLSchema#string

MacFarlane PW

http://www.w3.org/2001/XMLSchema#string

McKillop JH

http://www.w3.org/2001/XMLSchema#string

Packard CJ

http://www.w3.org/2001/XMLSchema#string

Shepherd J

http://www.w3.org/2001/XMLSchema#string

P304

1301-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

292185

http://www.w3.org/2001/XMLSchema#string

P356

10.1056/NEJM199511163332001

http://www.w3.org/2001/XMLSchema#string

P407

P433

20

http://www.w3.org/2001/XMLSchema#string

P478

333

http://www.w3.org/2001/XMLSchema#string

P577

1995-11-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15633138

http://www.w3.org/2001/XMLSchema#string

P698

7566020

http://www.w3.org/2001/XMLSchema#string

P921

hypercholesterolemia